Recognizing the critical role of mitochondrial dysfunction in assessing neuroprotective therapies after ischemic stroke, it is instrumental to find out how LIF alters the metabolic regulation in a tissue-specific manner. The gene discussed is LIF; the disease is ischemic stroke.